Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7051–7100 of 33107
In connection with the Merger, effective as of the Effective Time, Rohit Bhagat, Patricia Guinn, Bryan Lin, Xiaoning Jiao, Ying Sun, Joseph Velli, Yi Zhou and Lei Wang ceased to be directors of the Company.
In connection with the Merger, effective as of the Effective Time, Rohit Bhagat, Patricia Guinn, Bryan Lin, Xiaoning Jiao, Ying Sun, Joseph Velli, Yi Zhou and Lei Wang ceased to be directors of the Company.
each of Nora Goudroupi, Wayne Threatt, Von McConnell, Larry Epstein and Anggelos Skutaris resigned as directors of the Company
each of Nora Goudroupi, Wayne Threatt, Von McConnell, Larry Epstein and Anggelos Skutaris resigned as directors of the Company
each of Nora Goudroupi, Wayne Threatt, Von McConnell, Larry Epstein and Anggelos Skutaris resigned as directors of the Company
each of Nora Goudroupi, Wayne Threatt, Von McConnell, Larry Epstein and Anggelos Skutaris resigned as directors of the Company
each of Nora Goudroupi, Wayne Threatt, Von McConnell, Larry Epstein and Anggelos Skutaris resigned as directors of the Company
On September 2, 2024, Edward J. Fitzgerald notified EQT Exeter Real Estate Income Trust, Inc. (the “Company”) of his decision to resign as a member of the Company’s board of directors (the “Board”) and as Chairman of the Board effective immediately.
On September 2, 2024, Edward J. Fitzgerald notified EQT Exeter Real Estate Income Trust, Inc. (the “Company”) of his decision to resign as a member of the Company’s board of directors (the “Board”) and as Chairman of the Board effective immediately.
On September 3, 2024, the Company was informed by Yang Chiah Yee, vice president of worldwide sales, that he has accepted a similar role at another semiconductor company focused on the data-center market; the company does not compete with Power Integrations.
On August 28, 2024, James E. Moylan, Jr., (age 73), Senior Vice President and Chief Financial Officer, notified Ciena of his decision to retire in twelve months, effective August 28, 2025
On August 29, 2024, Kasra Moshkani, EVP, Verified of Clear Secure, Inc. (the “Company”, or “us”), informed us of his intention to resign to pursue other opportunities.
On September 3, 2024, David R. Guyer, M.D. and Anthony P. Adamis, M.D. resigned from the Board of Directors (the "Board") of EyePoint Pharmaceuticals, Inc. (the "Company") and all committees thereof, effective immediately.
On September 3, 2024, David R. Guyer, M.D. and Anthony P. Adamis, M.D. resigned from the Board of Directors (the "Board") of EyePoint Pharmaceuticals, Inc. (the "Company") and all committees thereof, effective immediately.
On September 3, 2024, Brent Handler, a member of the Board of Directors of Inspirato Incorporated (the "Company"), notified the Company of his intention to resign from the Company's Board of Directors, effective September 3, 2024.
On August 28, 2024, the Company entered into a Mutual Separation Agreement (the “Separation Agreement”) with Brendon B. Falconer, the Company’s former Senior Executive Vice President and Chief Financial Officer, pursuant to which the Company and Mr. Falconer mutually agreed that Mr. Falconer’s employment with the Company would terminate effective August 31, 2024.
Matteo Anversa, Executive Vice President of Finance, Chief Financial Officer and Treasurer of Gentherm Incorporated (the “Company”), and serving as the Company’s principal financial officer, notified the Company on August 5, 2024 of his decision to resign from such position effective September 1, 2024 to pursue another opportunity.
On August 31, 2024, James A. Lico notified the Board of Directors of Fortive Corporation (the “Company” or “Fortive”) of his decision to retire as President and Chief Executive Officer, and as a director, of the Company, effective upon the consummation of the proposed spin-off
In addition, on August 30, 2024, Charles E. McLaughlin notified the Company of his decision to retire as Senior Vice President and Chief Financial Officer of the Company by the end of the first quarter of 2025.
On August 31, 2024, James A. Lico notified the Board of Directors of Fortive Corporation (the “Company” or “Fortive”) of his decision to retire as President and Chief Executive Officer, and as a director, of the Company, effective upon the consummation of the proposed spin-off
On September 4, 2024, Voya Financial, Inc. (the “Company”) announced that Don Templin, Executive Vice President and Chief Financial Officer, informed the Company of his decision to retire from the Company.
On September 1, 2024, Frank D. Lee notified the Company of his resignation as a member of the Board and the committees thereof, effective as of September 3, 2024.
On August 28, 2024, James Healy, M.D., Ph.D., notified Bolt Biotherapeutics, Inc. (the “Company”) of his resignation as a member of the Company’s Board of Directors (the “Board”) and the committees thereof, effective as of September 3, 2024.
Mr. Hulette's appointment will fill the vacancy created by the recent retirement of Tony D. Whitaker from the Board of Directors of the Company.
On August 28, 2024, Mr. Matthew Barger notified iLearningEngines, Inc. (the “Company”) of his intention to resign from the board of directors of the Company (the “Board”) and all committees thereof.
succeed the Company’s current President and Chief Executive Officer, Dr. Stephen Schwartz, who as previously announced is retiring effective as of the Start Date
Steve Anderson notified the Company of his decision to resign from the Company's Board, effective September 6, 2024.
On September 2, 2024, Tamar Yehoshua notified the board of directors (the “Board”) of the Company of her intention to resign as a member of the Board, effective at the end of the day on September 13, 2024.
Glynis Bryan, the Company’s Chief Financial Officer, intends to retire as Chief Financial Officer effective December 31, 2024.
On August 28, 2024, we certified the election by our member, Columbus Electric Cooperative, Inc., of Zane Shanon Nunn to replace Chris Martinez, as the director representing them on our Board of Directors.
Christine Rupp departed her position as Chief Customer Officer of the Company
Greg Unis departed his position as Brand President of the Company
each of Dale S. Rosenthal, Michael S. Della Rocca, Edward A. Ryan and David M. Sparby (collectively, the “Prospective Everus Construction Directors”) are expected to resign as directors of the Company
each of Dale S. Rosenthal, Michael S. Della Rocca, Edward A. Ryan and David M. Sparby (collectively, the “Prospective Everus Construction Directors”) are expected to resign as directors of the Company
each of Dale S. Rosenthal, Michael S. Della Rocca, Edward A. Ryan and David M. Sparby (collectively, the “Prospective Everus Construction Directors”) are expected to resign as directors of the Company
each of Dale S. Rosenthal, Michael S. Della Rocca, Edward A. Ryan and David M. Sparby (collectively, the “Prospective Everus Construction Directors”) are expected to resign as directors of the Company
On September 3, 2024, STRATTEC SECURITY CORPORATION (the “Company”) announced the departure from the Company of Al-Waleed H. Hamdan, Vice President – Global Sales and Product Management and Chief Commercial Officer, effective October 3, 2024.
he will continue to serve as SITE Centers’ Executive Vice President, Chief Financial Officer and Treasurer until the Spin-Off Date (at which time he is expected to cease serving in such roles for SITE Centers)
David Sangster, Chief Operating Officer of Nutanix, Inc. (the “Company”), notified the Company of his decision to retire as Chief Operating Officer, effective October 31, 2024.
Stephen LaMond, PharmD., MBA resigned from his positions as Interim Chief Executive Officer and Chief Operating Officer of Peak Bio, Inc. (the “Company”), effective August 31, 2024.
On August 30, 2024, Joseph Jaeger, President, Americas of First Advantage Corporation (“First Advantage”), notified First Advantage of his intention to retire from such position, effective November 1, 2024 (the “Retirement Date”).
On August 28, 2024, Michael J. Fox notified Cue Biopharma, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company (the “Board”) and all committees thereof, effective on August 28, 2024.
On August 27, 2024, Kara Sprague, Executive Vice President and Chief Product Officer of F5, Inc., notified the Company that she will resign from her position effective November 2, 2024.
John Gandolfo retired from his positions as Chief Financial Officer, Treasurer and Secretary of Eyenovia, Inc. (the “Company”).
On August 27, 2024, Ali Behbahani gave notice of his intention to resign from the Board effective at the close of business on September 2, 2024.
Curtis McWilliams and Adam Markman have tendered their resignations from the board of directors
Curtis McWilliams and Adam Markman have tendered their resignations from the board of directors
Jonathan McNeill, M.D., the Company’s Chief Business Officer, and Susanna High, the Company’s Chief Operating Officer, each notified the Company of their intention to resign their employment.
Jonathan McNeill, M.D., the Company’s Chief Business Officer, and Susanna High, the Company’s Chief Operating Officer, each notified the Company of their intention to resign their employment.
As previously disclosed by the Company, Bruce Greenberg stepped down from his positions with the Company, including as the Company’s Senior Vice President of Finance, Interim Chief Financial Officer and principal financial officer and principal accounting officer as of the Effective Date.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.